NCT00025675 2018-06-26
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
Clinical Trials
9 trialsNCT01310855 2017-05-31
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
University College, London
Phase 2 Terminated
NCT00014170 2013-07-16
Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Completed
NCT00016991 2013-06-20
ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
Duke University
Phase 2 Completed
NCT00238251 2012-06-05
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
Swiss Cancer Institute
Phase 2 Completed
NCT00238797 2011-01-21
A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme
AstraZeneca
Phase 2 Completed
NCT00234442 2009-06-30
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
AstraZeneca
Phase 2 Terminated
NCT00135135 2008-06-03
Therapy for Children With Neuroblastoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00614809 2008-02-22
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown